The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 17, 2019
Filed:
Nov. 28, 2018
Applicant:
Forma Therapeutics, Inc., Watertown, MA (US);
Inventors:
Jennifer Lee, Arlington, MA (US);
Nicholas Barczak, Waterford, CT (US);
Jaime A. Escobedo, Natick, MA (US);
Chiara Conti, Belmont, MA (US);
Bingsong Han, Westwood, MA (US);
David R. Lancia, Jr., Boston, MA (US);
Cuixian Liu, Madison, CT (US);
Matthew W. Martin, Arlington, MA (US);
Pui Yee Ng, Waltham, MA (US);
Aleksandra Rudnitskaya, Roslindale, MA (US);
Jennifer R. Thomason, Clinton, MA (US);
Xiaozhang Zheng, Lexington, MA (US);
Assignee:
FORMA Therapeutics, Inc., Watertown, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 263/58 (2006.01); A61P 35/00 (2006.01); A61K 31/403 (2006.01); A61K 31/404 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61K 31/4188 (2006.01); A61K 31/4192 (2006.01); A61K 31/422 (2006.01); A61K 31/423 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/435 (2006.01); A61K 31/437 (2006.01); A61K 31/438 (2006.01); A61K 31/4439 (2006.01); A61K 31/4709 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/52 (2006.01); A61K 31/5377 (2006.01); A61K 31/5383 (2006.01); A61K 45/06 (2006.01); C07C 53/06 (2006.01); C07D 209/40 (2006.01); C07D 209/54 (2006.01); C07D 221/20 (2006.01); C07D 235/30 (2006.01); C07D 277/82 (2006.01); C07D 401/04 (2006.01); C07D 401/06 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 405/04 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 417/06 (2006.01); C07D 473/00 (2006.01); C07D 487/04 (2006.01); C07D 491/056 (2006.01); C07D 491/107 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 263/58 (2013.01); A61K 31/403 (2013.01); A61K 31/404 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/4188 (2013.01); A61K 31/4192 (2013.01); A61K 31/422 (2013.01); A61K 31/423 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/435 (2013.01); A61K 31/437 (2013.01); A61K 31/438 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/52 (2013.01); A61K 31/5377 (2013.01); A61K 31/5383 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07C 53/06 (2013.01); C07D 209/40 (2013.01); C07D 209/54 (2013.01); C07D 221/20 (2013.01); C07D 235/30 (2013.01); C07D 277/82 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 405/04 (2013.01); C07D 413/06 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/06 (2013.01); C07D 473/00 (2013.01); C07D 487/04 (2013.01); C07D 491/056 (2013.01); C07D 491/107 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for example, cell proliferative diseases.